Advisor Group Holdings, Inc. Gt Biopharma, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.22 - $0.28 $55 - $70	-253 Reduced 19.92%	1,017 $0
Q3 2023 Nov 13, 2023	BUY	$0.24 - $0.35 $60 - $88	253 Added 24.88%	1,270 $0
Q1 2023 May 12, 2023	SELL	$0.46 - $1.05 $46 - $107	-102 Reduced 9.12%	1,017 $0
Q4 2022 Feb 10, 2023	BUY	$0.89 - $58.2 $12 - $814	14 Added 1.27%	1,119 $0
Q2 2022 Aug 10, 2022	BUY	$1.64 - $3.11 $68 - $130	42 Added 3.95%	1,105 $4,000
Q1 2022 May 04, 2022	SELL	$2.6 - $3.3 $1,528 - $1,940	-588 Reduced 35.61%	1,063 $4,000
Q3 2021 Nov 05, 2021	SELL	$6.68 - $15.26 $8,630 - $19,715	-1,292 Reduced 43.9%	1,651 $11,000
Q2 2021 Aug 02, 2021	BUY	$7.19 - $18.96 $11,000 - $29,008	1,530 Added 108.28%	2,943 $45,000
Q1 2021 May 13, 2021	BUY	$4.4 - $8.84 $6,217 - $12,490	1,413 New	1,413 $10,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $81.7M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.